Correction to “A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor ɣ with Excellent Effect on Insulin Resistance and Type 2 Diabetes”

Abstract

In the above article [Liu H-J, Zhang C-Y, Song F, Xiao T, Meng J, Zhang Q, Liang C-L, Li S, Wang J, Zhang B, Liu Y-R, Sun T, and Zhou H-G (2015) J Pharmacol Exp Ther 353: [573-581][1] DOI: <https://doi.org/10.1124/jpet.115.223107>], the authors discovered a couple of mistakes were accidentally